Mammalian target of rapamycin complex 2 (mTORC2) controls glycolytic gene expression by regulating Histone H3 Lysine 56 acetylation

References

• Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149:274–293. doi: 10.1016/j.cell.2012.03.017. PMID:22500797
   PubMed Web of Science ®Google Scholar
• Laplante M, Sabatini DM. mTOR signaling at a glance. J Cell Sci. 2009;122:3589–3594. doi: 10.1242/jcs.051011. PMID:19812304
   PubMed Web of Science ®Google Scholar
• Frias MA, Thoreen CC, Jaffe JD, et al. mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr Biol. 2006;16:1865–1870. doi: 10.1016/j.cub.2006.08.001. PMID:16919458
   PubMed Web of Science ®Google Scholar
• Sarbassov DD, Guertin DA, Ali SM, et al. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 2005;307:1098–1101. doi: 10.1126/science.1106148. PMID:15718470
   PubMed Web of Science ®Google Scholar
• Yang Q, Inoki K, Ikenoue T, et al. Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity. Genes Dev. 2006;20:2820–2832. doi: 10.1101/gad.1461206. PMID:17043309
   PubMed Web of Science ®Google Scholar
• Huang J, Manning BD. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J. 2008;412:179–190. doi: 10.1042/BJ20080281. PMID:18466115
   PubMed Web of Science ®Google Scholar
• Gaubitz C, Prouteau M, Kusmider B, et al. TORC2 Structure and Function. Trends Biochem Sci. 2016;41:532–545. doi: 10.1016/j.tibs.2016.04.001. PMID:27161823
   PubMed Web of Science ®Google Scholar
• Betz C, Hall MN. Where is mTOR and what is it doing there? J Cell Biol. 2013;203:563–574. doi: 10.1083/jcb.201306041. PMID:24385483
   PubMed Web of Science ®Google Scholar
• Rosner M, Hengstschlager M. Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1. Hum Mol Genet. 2008;17:2934–2948. doi: 10.1093/hmg/ddn192. PMID:18614546
   PubMed Web of Science ®Google Scholar
• Workman JJ, Chen H, Laribee RN. Environmental signaling through the mechanistic target of rapamycin complex 1: mTORC1 goes nuclear. Cell Cycle. 2014;13:714–725. doi: 10.4161/cc.28112. PMID:24526113
   PubMed Web of Science ®Google Scholar
• Tsang CK, Liu H, Zheng XF. mTOR binds to the promoters of RNA polymerase I- and III-transcribed genes. Cell Cycle. 2010;9:953–957. doi: 10.4161/cc.9.5.10876. PMID:20038818
   PubMed Web of Science ®Google Scholar
• Vazquez-Martin A, Cufi S, Oliveras-Ferraros C, et al. Raptor, a positive regulatory subunit of mTOR complex 1, is a novel phosphoprotein of the rDNA transcription machinery in nucleoli and chromosomal nucleolus organizer regions (NORs). Cell Cycle. 2011;10:3140–3152. doi: 10.4161/cc.10.18.17376. PMID:21900751
   PubMed Web of Science ®Google Scholar
• Mayer C, Grummt I. Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases. Oncogene. 2006;25:6384–6391. doi: 10.1038/sj.onc.1209883. PMID:17041624
   PubMed Web of Science ®Google Scholar
• Xie W, Song C, Young NL, et al. Histone h3 lysine 56 acetylation is linked to the core transcriptional network in human embryonic stem cells. Mol Cell. 2009;33:417–427. doi: 10.1016/j.molcel.2009.02.004. PMID:19250903
   PubMed Web of Science ®Google Scholar
• Tan Y, Xue Y, Song C, et al. Acetylated histone H3K56 interacts with Oct4 to promote mouse embryonic stem cell pluripotency. Proc Natl Acad Sci U S A. 2013;110:11493–11498. doi: 10.1073/pnas.1309914110. PMID:23798425
   PubMed Web of Science ®Google Scholar
• Kong S, Kim SJ, Sandal B, et al. The type III histone deacetylase Sirt1 protein suppresses p300-mediated histone H3 lysine 56 acetylation at Bclaf1 promoter to inhibit T cell activation. J Biol Chem. 2011;286:16967–16975. doi: 10.1074/jbc.M111.218206. PMID:21454709
   PubMed Web of Science ®Google Scholar
• Das C, Lucia MS, Hansen KC, et al. CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature. 2009;459:113–117. doi: 10.1038/nature07861. PMID:19270680
   PubMed Web of Science ®Google Scholar
• Vempati RK, Jayani RS, Notani D, et al. p300-mediated acetylation of histone H3 lysine 56 functions in DNA damage response in mammals. J Biol Chem. 2010;285:28553–28564. doi: 10.1074/jbc.M110.149393. PMID:20587414
   PubMed Web of Science ®Google Scholar
• Battu A, Ray A, Wani AA. ASF1A and ATM regulate H3K56-mediated cell-cycle checkpoint recovery in response to UV irradiation. Nucleic Acids Res. 2011;39:7931–7945. doi: 10.1093/nar/gkr523. PMID:21727091
   PubMed Web of Science ®Google Scholar
• Houtkooper RH, Pirinen E, Auwerx J. Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol. 2012;13:225–238. PMID:22395773
   PubMed Web of Science ®Google Scholar
• Michishita E, Park JY, Burneskis JM, et al. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell. 2005;16:4623–4635. doi: 10.1091/mbc.E05-01-0033. PMID:16079181
   PubMed Web of Science ®Google Scholar
• Kugel S, Mostoslavsky R. Chromatin and beyond: the multitasking roles for SIRT6. Trends Biochem Sci. 2014;39:72–81. doi: 10.1016/j.tibs.2013.12.002. PMID:24438746
   PubMed Web of Science ®Google Scholar
• Kugel S, Feldman JL, Klein MA, et al. Identification of and Molecular Basis for SIRT6 Loss-of-Function Point Mutations in Cancer. Cell Rep. 2015;13:479–488. doi: 10.1016/j.celrep.2015.09.022. PMID:26456828
   PubMed Web of Science ®Google Scholar
• Cai J, Zuo Y, Wang T, et al. A crucial role of SUMOylation in modulating Sirt6 deacetylation of H3 at lysine 56 and its tumor suppressive activity. Oncogene. 2016;35:4949–4456. doi: 10.1038/onc.2016.24.
   PubMed Web of Science ®Google Scholar
• Ha CW, Huh WK. Rapamycin increases rDNA stability by enhancing association of Sir2 with rDNA in Saccharomyces cerevisiae. Nucleic Acids Res. 2011;39:1336–1350. doi: 10.1093/nar/gkq895. PMID:20947565
   PubMed Web of Science ®Google Scholar
• Chen H, Fan M, Pfeffer LM, et al. The histone H3 lysine 56 acetylation pathway is regulated by target of rapamycin (TOR) signaling and functions directly in ribosomal RNA biogenesis. Nucleic Acids Res. 2012;40:6534–6546. doi: 10.1093/nar/gks345. PMID:22553361
   PubMed Web of Science ®Google Scholar
• Masui K, Tanaka K, Akhavan D, et al. mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc. Cell Metab. 2013;18:726–739. doi: 10.1016/j.cmet.2013.09.013. PMID:24140020
   PubMed Web of Science ®Google Scholar
• Duvel K, Yecies JL, Menon S, et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell. 2010;39:171–183. doi: 10.1016/j.molcel.2010.06.022. PMID:20670887
   PubMed Web of Science ®Google Scholar
• Sebastian C, Zwaans BM, Silberman DM, et al. The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell. 2012;151:1185–1199. doi: 10.1016/j.cell.2012.10.047. PMID:23217706
   PubMed Web of Science ®Google Scholar
• Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003;33 Suppl:245–254. doi: 10.1038/ng1089. PMID:12610534
   PubMed Web of Science ®Google Scholar
• Workman JJ, Chen H, Laribee RN. Saccharomyces cerevisiae TORC1 Controls Histone Acetylation by Signaling Through the Sit4/PP6 Phosphatase to Regulate Sirtuin Deacetylase Nuclear Accumulation. Genetics. 2016;203:1733–1746. doi: 10.1534/genetics.116.188458. PMID:27343235
   PubMed Web of Science ®Google Scholar
• Sarbassov DD, Ali SM, Sengupta S, et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell. 2006;22:159–168. doi: 10.1016/j.molcel.2006.03.029. PMID:16603397
   PubMed Web of Science ®Google Scholar
• Lee JV, Carrer A, Shah S, et al. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metab. 2014;20:306–319. doi: 10.1016/j.cmet.2014.06.004. PMID:24998913
   PubMed Web of Science ®Google Scholar
• Huang J, Dibble CC, Matsuzaki M, et al. The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Mol Cell Biol. 2008;28:4104–4115. doi: 10.1128/MCB.00289-08. PMID:18411301
   PubMed Web of Science ®Google Scholar
• Huang J, Wu S, Wu CL, et al. Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors. Cancer Res. 2009;69:6107–6114. doi: 10.1158/0008-5472.CAN-09-0975. PMID:19602587
   PubMed Web of Science ®Google Scholar
• Liu P, Guo J, Gan W, et al. Dual phosphorylation of Sin1 at T86 and T398 negatively regulates mTORC2 complex integrity and activity. Protein Cell. 2014;5:171–177. doi: 10.1007/s13238-014-0021-8. PMID:24481632
   PubMed Web of Science ®Google Scholar
• Xu F, Zhang Q, Zhang K, et al. Sir2 deacetylates histone H3 lysine 56 to regulate telomeric heterochromatin structure in yeast. Mol Cell. 2007;27:890–900. doi: 10.1016/j.molcel.2007.07.021. PMID:17889663
   PubMed Web of Science ®Google Scholar
• Maas NL, Miller KM, DeFazio LG, et al. Cell cycle and checkpoint regulation of histone H3 K56 acetylation by Hst3 and Hst4. Mol Cell. 2006;23:109–119. doi: 10.1016/j.molcel.2006.06.006. PMID:16818235
   PubMed Web of Science ®Google Scholar
• Yuan J, Pu M, Zhang Z, et al. Histone H3-K56 acetylation is important for genomic stability in mammals. Cell Cycle. 2009;8:1747–1753. doi: 10.4161/cc.8.11.8620. PMID:19411844
   PubMed Web of Science ®Google Scholar
• Michishita E, McCord RA, Boxer LD, et al. Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6. Cell Cycle. 2009;8:2664–2666. doi: 10.4161/cc.8.16.9367. PMID:19625767
   PubMed Web of Science ®Google Scholar
• Mostoslavsky R, Chua KF, Lombard DB, et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell. 2006;124:315–329. doi: 10.1016/j.cell.2005.11.044. PMID:16439206
   PubMed Web of Science ®Google Scholar
• McCord RA, Michishita E, Hong T, et al. SIRT6 stabilizes DNA-dependent protein kinase at chromatin for DNA double-strand break repair. Aging (Albany NY). 2009;1:109–121. doi: 10.18632/aging.100011. PMID:20157594
   PubMedGoogle Scholar
• Ghosh S, Liu B, Wang Y, et al. Lamin A Is an Endogenous SIRT6 Activator and Promotes SIRT6-Mediated DNA Repair. Cell Rep. 2015;13:1396–1406. doi: 10.1016/j.celrep.2015.10.006. PMID:26549451
   PubMed Web of Science ®Google Scholar
• Drouet J, Delteil C, Lefrancois J, et al. DNA-dependent protein kinase and XRCC4-DNA ligase IV mobilization in the cell in response to DNA double strand breaks. J Biol Chem. 2005;280:7060–7069. doi: 10.1074/jbc.M410746200. PMID:15520013
   PubMed Web of Science ®Google Scholar
• Michishita E, McCord RA, Berber E, et al. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature. 2008;452:492–496. doi: 10.1038/nature06736. PMID:18337721
   PubMed Web of Science ®Google Scholar
• Pan PW, Feldman JL, Devries MK, et al. Structure and biochemical functions of SIRT6. J Biol Chem. 2011;286:14575–14587. doi: 10.1074/jbc.M111.218990. PMID:21362626
   PubMed Web of Science ®Google Scholar
• Grimley R, Polyakova O, Vamathevan J, et al. Over expression of wild type or a catalytically dead mutant of Sirtuin 6 does not influence NFkappaB responses. PLoS One. 2012;7:e39847. doi: 10.1371/journal.pone.0039847. PMID:22792191
   PubMed Web of Science ®Google Scholar
• Tanaka K, Babic I, Nathanson D, et al. Oncogenic EGFR signaling activates an mTORC2-NF-kappaB pathway that promotes chemotherapy resistance. Cancer Discov. 2011;1:524–538. doi: 10.1158/2159-8290.CD-11-0124. PMID:22145100
   PubMed Web of Science ®Google Scholar
• Yin Y, Hua H, Li M, et al. mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR. Cell Research. 2016;26:46–65. doi: 10.1038/cr.2015.133. PMID:26584640
   PubMed Web of Science ®Google Scholar
• Wu SH, Bi JF, Cloughesy T, et al. Emerging function of mTORC2 as a core regulator in glioblastoma: metabolic reprogramming and drug resistance. Cancer Biol Med. 2014;11:255–263. PMID:25610711
   PubMedGoogle Scholar
• Masri J, Bernath A, Martin J, et al. mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor. Cancer Res. 2007;67:11712–11720. doi: 10.1158/0008-5472.CAN-07-2223. PMID:18089801
   PubMed Web of Science ®Google Scholar
• Kugel S, Sebastian C, Fitamant J, et al. SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b. Cell. 2016;165:1401–1415. doi: 10.1016/j.cell.2016.04.033. PMID:27180906
   PubMed Web of Science ®Google Scholar
• Faulk C, Dolinoy DC. Timing is everything: the when and how of environmentally induced changes in the epigenome of animals. Epigenetics. 2011;6:791–797. doi: 10.4161/epi.6.7.16209. PMID:21636976
   PubMed Web of Science ®Google Scholar
• Rohde JR, Cardenas ME. The tor pathway regulates gene expression by linking nutrient sensing to histone acetylation. Mol Cell Biol. 2003;23:629–635. doi: 10.1128/MCB.23.2.629-635.2003. PMID:12509460
   PubMed Web of Science ®Google Scholar
• Chen H, Workman JJ, Tenga A, et al. Target of rapamycin signaling regulates high mobility group protein association to chromatin, which functions to suppress necrotic cell death. Epigenetics Chromatin. 2013;6:29. doi: 10.1186/1756-8935-6-29. PMID:24044743
   PubMed Web of Science ®Google Scholar
• Gong H, Qian H, Ertl R, et al. Histone modifications change with age, dietary restriction and rapamycin treatment in mouse brain. Oncotarget. 2015;6:15882–15890. doi: 10.18632/oncotarget.4137. PMID:26021816
   PubMed Web of Science ®Google Scholar
• Ghosh HS, McBurney M, Robbins PD. SIRT1 negatively regulates the mammalian target of rapamycin. PLoS One. 2010;5:e9199. doi: 10.1371/journal.pone.0009199. PMID:20169165
   PubMed Web of Science ®Google Scholar
• Hong S, Zhao B, Lombard DB, et al. Cross-talk between sirtuin and mammalian target of rapamycin complex 1 (mTORC1) signaling in the regulation of S6 kinase 1 (S6K1) phosphorylation. J Biol Chem. 2014;289:13132–13141. doi: 10.1074/jbc.M113.520734. PMID:24652283
   PubMed Web of Science ®Google Scholar
• Guo W, Qian L, Zhang J, et al. Sirt1 overexpression in neurons promotes neurite outgrowth and cell survival through inhibition of the mTOR signaling. J Neurosci Res. 2011;89:1723–1736. doi: 10.1002/jnr.22725. PMID:21826702
   PubMed Web of Science ®Google Scholar
• Glidden EJ, Gray LG, Vemuru S, et al. Multiple site acetylation of Rictor stimulates mammalian target of rapamycin complex 2 (mTORC2)-dependent phosphorylation of Akt protein. J Biol Chem. 2012;287:581–588. doi: 10.1074/jbc.M111.304337. PMID:22084251
   PubMed Web of Science ®Google Scholar
• Miteva YV, Cristea IM. A proteomic perspective of Sirtuin 6 (SIRT6) phosphorylation and interactions and their dependence on its catalytic activity. Mol Cell Proteomics. 2014;13:168–183. doi: 10.1074/mcp.M113.032847. PMID:24163442
   PubMed Web of Science ®Google Scholar
• Thirumurthi U, Shen J, Xia W, et al. MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer. Sci Signal. 2014;7:ra71. doi: 10.1126/scisignal.2005076. PMID:25074979
   PubMed Web of Science ®Google Scholar
• Tee AR, Fingar DC, Manning BD, et al. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci U S A. 2002;99:13571–13576. doi: 10.1073/pnas.202476899. PMID:12271141
   PubMed Web of Science ®Google Scholar
• Neuman NA, Henske EP. Non-canonical functions of the tuberous sclerosis complex-Rheb signalling axis. EMBO Mol Med. 2011;3:189–200. doi: 10.1002/emmm.201100131. PMID:21412983
   PubMed Web of Science ®Google Scholar
• Rosner M, Freilinger A, Hengstschlager M. Akt regulates nuclear/cytoplasmic localization of tuberin. Oncogene. 2007;26:521–531. doi: 10.1038/sj.onc.1209812. PMID:16862180
   PubMed Web of Science ®Google Scholar
• Pradhan SA, Rather MI, Tiwari A, et al. Evidence that TSC2 acts as a transcription factor and binds to and represses the promoter of Epiregulin. Nucleic Acids Res. 2014;42:6243–6255. doi: 10.1093/nar/gku278. PMID:24748662
   PubMed Web of Science ®Google Scholar
• Zhang F, Zhang X, Li M, et al. mTOR complex component Rictor interacts with PKCzeta and regulates cancer cell metastasis. Cancer Res. 2010;70:9360–9370. doi: 10.1158/0008-5472.CAN-10-0207. PMID:20978191
   PubMed Web of Science ®Google Scholar
• Sparks CA, Guertin DA. Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy. Oncogene. 2010;29:3733–3744. doi: 10.1038/onc.2010.139. PMID:20418915
   PubMed Web of Science ®Google Scholar
• Guertin DA, Stevens DM, Saitoh M, et al. mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice. Cancer Cell. 2009;15:148–159. doi: 10.1016/j.ccr.2008.12.017. PMID:19185849
   PubMed Web of Science ®Google Scholar
• Hietakangas V, Cohen SM. TOR complex 2 is needed for cell cycle progression and anchorage-independent growth of MCF7 and PC3 tumor cells. BMC Cancer. 2008;8:282. doi: 10.1186/1471-2407-8-282. PMID:18831768
   PubMed Web of Science ®Google Scholar
• Morrison Joly M, Hicks DJ, Jones B, et al. Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers. Cancer Res. 2016. doi: 10.1158/0008-5472.CAN-15-3393. PMID:27013195
   PubMedGoogle Scholar
• Gulhati P, Cai Q, Li J, et al. Targeted inhibition of mammalian target of rapamycin signaling inhibits tumorigenesis of colorectal cancer. Clin Cancer Res. 2009;15:7207–7216. doi: 10.1158/1078-0432.CCR-09-1249. PMID:19934294
   PubMed Web of Science ®Google Scholar
• Cheng H, Zou Y, Ross JS, et al. RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 Inhibitors. Cancer Discov. 2015;5:1262–1270. doi: 10.1158/2159-8290.CD-14-0971. PMID:26370156
   PubMed Web of Science ®Google Scholar
• Yuan M, Pino E, Wu L, et al. Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2. J Biol Chem. 2012;287:29579–29588. doi: 10.1074/jbc.M112.386854. PMID:22773877
   PubMed Web of Science ®Google Scholar
• Fraga MF, Ballestar E, Villar-Garea A, et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet. 2005;37:391–400. doi: 10.1038/ng1531. PMID:15765097
   PubMed Web of Science ®Google Scholar
• Khan SA, Reddy D, Gupta S. Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment? World J Biol Chem. 2015;6:333–345. doi: 10.4331/wjbc.v6.i4.333. PMID:26629316
   PubMedGoogle Scholar
• Feng J, Yan PF, Zhao HY, et al. SIRT6 suppresses glioma cell growth via induction of apoptosis, inhibition of oxidative stress and suppression of JAK2/STAT3 signaling pathway activation. Oncol Rep. 2016;35:1395–402. doi: 10.3892/or.2015.4477. PMID:26648570
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408. doi: 10.1006/meth.2001.1262. PMID:11846609
   PubMed Web of Science ®Google Scholar